Poland
# |
Name |
Goodwill |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 18.27 M
|
Dec. 31, 2023 | USD 10.78 | -0.36% |
|
Poland |
|
2 |
USD 0.00
|
Dec. 31, 2023 | USD 12.77 | 1.67% |
|
Poland |
|
3 |
USD 0.00
|
Dec. 31, 2023 | USD 1.88 | 0.22% |
|
Poland |
|
4 |
USD 0.00
|
Dec. 31, 2023 | USD 9.53 | -0.94% |
|
Poland |
|
5 |
USD 0.00
|
Dec. 31, 2023 | USD 6.78 | -1.52% |
|
Poland |
The Clinical Trials company in Poland with the highest Goodwill is Selvita S.A. (Warsaw Stock Exchange: SLV.WA) at USD 18.27 M.
The Clinical Trials company in Poland with the lowest Goodwill is Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU.WA) at USD 0.00.
The top 10 Clinical Trials companies in Poland by Goodwill are Selvita S.A., Captor Therapeutics Spolka Akcyjna, Medinice S.A., Poltreg S.A. and Ryvu Therapeutics S.A..
The bottom 10 Clinical Trials companies in Poland by Goodwill are Ryvu Therapeutics S.A., Poltreg S.A., Medinice S.A., Captor Therapeutics Spolka Akcyjna and Selvita S.A..